Drug Trial Radar · NCT05482295
Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Last checked: Nov 20, 2026Latest source record: Jun 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
540
Planned (sponsor's estimate)
Start
Sep 2025
Primary completion
May 2026
Study completion May 2026
Sponsor
- Lead sponsor
- PT Bio FarmaIndustry
- Sponsor type
- Industry
- Collaborators
- RSUP Prof. Dr. I.G.N.G. Ngoerahal
- First posted
- Aug 1, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 10 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a phase 3, experimental, randomized, observer-blind, lot to lot consistency study. The primary objective of this study is to assess the protectivity of In-House Recombinant Hepatitis B vaccine 28 days after 3 doses immunization.
Conditions
- Vaccine Reaction
- Vaccine Adverse Reaction
Interventions
In-House Recombinant Hepatitis B (Bio Farma) vaccineBiological
3 doses of In-House Recombinant Hepatitis B (Bio Farma) vaccine
Registered Hepatitis B vaccine recombinant (Engerix-B)Biological
3 doses of Registered Hepatitis B vaccine recombinant (Engerix-B)
Primary outcomes
What the sponsor says the trial is designed to measure.
- ProtectivityTime frame: 28 days after the primary series of Hepatitis B vaccination
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.